Zdrowie i gospodarka · 20/05/2016

FDA Releases Draft Guidance for Developing Drugs for COPD Treatment

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies design clinical trials for new treatments of chronic obstructive pulmonary disease (COPD). The guidance, which updates a 2007 version, includes information on the St. George's Respiratory Questionnaire (SGRQ).